Retratrutide
Retratrutide is a cutting-edge peptide developed by Eli Lilly, designed to address obesity and type 2 diabetes through a unique triple-action mechanism. It activates three key hormone receptors—GLP-1, GIP, and glucagon—which together help regulate blood sugar, suppress appetite, and boost metabolic rate
Clinical trials have shown impressive results: participants experienced up to 22% weight loss over 11 months, significantly outperforming other peptides like semaglutide. It also improves insulin sensitivity, reduces triglycerides, and may offer cardiovascular and liver health benefits
The benefits and effects of Retatrutide include:
Stimulating insulin release and reducing the release of glucagon, which supports weight loss and helps address obesity and type 2 diabetes.
- Improving blood glucose levels.
- Improving blood pressure.
- Reducing body weight by decreasing energy intake and increasing energy expenditure.
Check out Jay Campbell's website, which is an excellent source for peptide research.
